Monoclonal gammopathy of undetermined significance (MGUS) is associated with an increased frequency of Epstein-Barr Virus (EBV) latently infected B lymphocytes in long-term renal transplant patients

Transplantation Proceedings

Volumn 36, Issue 9, 2004, Pages 2679-2682

  Babel, N ^a   Schwarzmann, F ^b   Pruss, A ^a   Volk, H D ^a   Reinke, P ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; FEMALE; GENE EXPRESSION; GENETIC LINKAGE; GENETIC TRANSCRIPTION; HUMAN; KIDNEY TRANSPLANTATION; LATENT VIRUS INFECTION; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; VIRUS LATENCY; VIRUS LOAD;

ADULT; B-LYMPHOCYTES; FEMALE; FOLLOW-UP STUDIES; HERPESVIRUS 4, HUMAN; HUMANS; KIDNEY TRANSPLANTATION; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; PARAPROTEINEMIAS; POSTOPERATIVE COMPLICATIONS; REFERENCE VALUES; RNA, VIRAL; VIRAL LOAD;

EID: 11144298080     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2004.09.046     Document Type: Article

References (14)

1. H. Gregersen, L. Mellemkjaer, J.S. Ibsen The impact of M-component type and immunoglobulin concentration on the risk of malignant transformation in patients with monoclonal gammopathy of undetermined significance Haematologica 86 2001 1172
2. R.A. Kyle, T.M. Therneau, S.V. Rajkumar A long-term study of prognosis in monoclonal gammopathy of undetermined significance N Engl J Med 346 2002 564
3. A.D. Badley, D.F. Portela, R. Patel Development of monoclonal gammopathy precedes the development of Epstein-Barr virus-induced posttransplant lymphoproliferative disorder Liver Transpl Surg 2 1996 375
4. D.W. Hanto Classification of Epstein-Barr virus-associated posttransplant lymphoproliferative diseases: Implications for understanding their pathogenesis and developing rational treatment strategies Annu Rev Med 46 1995 381
5. N. Babel, F. Schwarzmann, N. Prang Association between Epstein-Barr virus infection and late acute transplant rejection in long-term transplant patients Transplantation 72 2001 736
6. G.C. Faulkner, A.S. Krajewski, D.H. Crawford The ins and outs of EBV infection Trends Microbiol 8 2000 185
7. G.J. Babcock, D. Hochberg, A.D. Thorley-Lawson The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell Immunity 13 2000 497
8. P.A. Hopwood, L. Brooks, R. Parratt Persistent Epstein-Barr virus infection: unrestricted latent and lytic viral gene expression in healthy immunosuppressed transplant recipients Transplantation 74 2002 194
9. S. Salmon, M. Seligmann B cell neoplasia in man Lancet 3 1974 1230
10. C. Chakalarovski, P.H. Lang, C.L. Buisson Monoclonal immunoglobulins in kidney transplantation Characterisation, evolution and risk factors Presse Med 27 1991 2033
11. T. Ishiyama, M. Koike, K. Watanabe Natural killer (NK) lymphocytosis induced by Epstein-Barr virus (EBV) reactivation in monoclonal gammopathy of undetermined significance (MGUS) Clin Exp Immunol 105 1996 46
12. S. Ode-Hakim, F. Kern, E. Fietze Association between CMV-related graft injury and circulating cytokine-producing CD8+ memory cells Transplant Proc 27 1995 951
13. H. Dolstra, F. Preijerś, E. Van de Wiel-van Kemenade Expansion of CD8+CD57+ T cells after allogeneic BMT is related with a low incidence of relapse and with cytomegalovirus infection Br J Haematol 90 1995 300
14. H. Fukuda, H. Nakamura, H. Tominaga Marked increase of CD8+S6F1+ and CD8+CD57+ cells in patients with graft-versus-host disease after allogeneic bone marrow transplantation Bone Marrow Transplant 13 1994 181